Literature DB >> 30191294

White paper: statement on conflicts of interest.

Julian Bion1, Massimo Antonelli2, LLuis Blanch3, J Randall Curtis4, Christiane Druml5, Bin Du6, Flavia R Machado7, Charles Gomersall8, Christiane Hartog9, Mitchell Levy10, John Myburgh11, Gordon Rubenfeld12, Charles Sprung13.   

Abstract

INTRODUCTION: Conflicts of interest are a normal part of human social intercourse. They become problematic when there is a power differential between participants in the setting of relationships requiring a high degree of trust, as in healthcare. In this white paper we consider how these conflicts may be detected and mitigated.
METHODS: Following Medline search and reference chaining, we undertook a narrative review of the literature with iterative discussion.
RESULTS: Conflicts of interest may be financial, professional or personal, and may operate at the level of the individual or the organisation. Unmanaged, they become a source of bias which places the interests of the professional or the organisation before those of the patient. Reported with increasing frequency, conflicts damage trust, harm patients, and defraud the health system. We make 15 recommendations for minimising conflicts of interest.
CONCLUSIONS: Nationally funded open-access registries should be established to permit complete disclosure of financial, professional, and personal relationships with the potential for driving bias in research, clinical practice, or health management. Governance of disclosure should be the responsibility of employing organisations through annual staff appraisals, audited by national research integrity committees. Research fraud should incur suspension of the license to practice. Organisations should monitor staff perceptions of ethical climate to enhance awareness of staff behaviours and the potential for misconduct driven by academic pressures. Clear separation of advisory and voting roles is needed in best practice guideline panels. Professional societies and scientific journals should display conflict of interest policies for their own staff and officers as well as for speakers and authors. Undergraduates should not be exposed to pharmaceutical promotions masquerading as education. Undergraduate and postgraduate training programmes should include teaching about managing conflicts of interest and identifying research misconduct.

Entities:  

Keywords:  Bias; Conflict of interest; Medical education; Professionalism; Research governance

Mesh:

Year:  2018        PMID: 30191294     DOI: 10.1007/s00134-018-5349-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  64 in total

1.  Laboratory test ordering at physician offices with and without on-site laboratories.

Authors:  Tara F Bishop; Alex D Federman; Joseph S Ross
Journal:  J Gen Intern Med       Date:  2010-06-08       Impact factor: 5.128

2.  The conflict vitae: a CV for the new millennium.

Authors:  Gordon D Rubenfeld
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

3.  Retraction Note to multiple articles in Tumor Biology.

Authors:  Torgny Stigbrand
Journal:  Tumour Biol       Date:  2017-04-20

4.  Dozens of US doctors charged in "historic" fraud crackdown.

Authors:  Owen Dyer
Journal:  BMJ       Date:  2018-07-05

5.  Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.

Authors:  Colette DeJong; Thomas Aguilar; Chien-Wen Tseng; Grace A Lin; W John Boscardin; R Adams Dudley
Journal:  JAMA Intern Med       Date:  2016-08-01       Impact factor: 21.873

6.  A randomized study of how physicians interpret research funding disclosures.

Authors:  Aaron S Kesselheim; Christopher T Robertson; Jessica A Myers; Susannah L Rose; Victoria Gillet; Kathryn M Ross; Robert J Glynn; Steven Joffe; Jerry Avorn
Journal:  N Engl J Med       Date:  2012-09-20       Impact factor: 91.245

7.  Understanding ethical climate, moral distress, and burnout: a novel tool and a conceptual framework.

Authors:  Elizabeth Dzeng; J Randall Curtis
Journal:  BMJ Qual Saf       Date:  2018-04-18       Impact factor: 7.035

8.  Effect of exposure to small pharmaceutical promotional items on treatment preferences.

Authors:  David Grande; Dominick L Frosch; Andrew W Perkins; Barbara E Kahn
Journal:  Arch Intern Med       Date:  2009-05-11

9.  Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.

Authors:  Susan F Wood; Joanna Podrasky; Meghan A McMonagle; Janani Raveendran; Tyler Bysshe; Alycia Hogenmiller; Adriane Fugh-Berman
Journal:  PLoS One       Date:  2017-10-25       Impact factor: 3.240

10.  Outcome in patients perceived as receiving excessive care across different ethical climates: a prospective study in 68 intensive care units in Europe and the USA.

Authors:  D D Benoit; H I Jensen; J Malmgren; V Metaxa; A K Reyners; M Darmon; K Rusinova; D Talmor; A P Meert; L Cancelliere; L Zubek; P Maia; A Michalsen; S Vanheule; E J O Kompanje; J Decruyenaere; S Vandenberghe; S Vansteelandt; B Gadeyne; B Van den Bulcke; E Azoulay; R D Piers
Journal:  Intensive Care Med       Date:  2018-05-28       Impact factor: 17.440

View more
  3 in total

Review 1.  [Overtreatment in intensive care medicine-recognition, designation, and avoidance : Position paper of the Ethics Section of the DIVI and the Ethics section of the DGIIN].

Authors:  Andrej Michalsen; Gerald Neitzke; Jochen Dutzmann; Annette Rogge; Anna-Henrikje Seidlein; Susanne Jöbges; Hilmar Burchardi; Christiane Hartog; Friedemann Nauck; Fred Salomon; Gunnar Duttge; Guido Michels; Kathrin Knochel; Stefan Meier; Peter Gretenkort; Uwe Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-03-01       Impact factor: 0.840

2.  Perceptions of artificial intelligence in healthcare: findings from a qualitative survey study among actors in France.

Authors:  M-C Laï; M Brian; M-F Mamzer
Journal:  J Transl Med       Date:  2020-01-09       Impact factor: 5.531

3.  Conflict of Interest: Are Iranian Breast Cancer Specialists Prone to it?

Authors:  Amirpasha Ebrahimi; Sanaz Zand; Fahimeh Bagheri Amiri; Farhad Shahi; Ali Jafarian; Ahmad Kaviani
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.